Topical Itraconazole for the Treatment of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome or High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial.

JAMA Dermatol

Department of Dermatology, Stanford University, Stanford, California.

Published: September 2019

This phase 2, open-label, placebo-controlled examines topical itraconazole as a treatment for basal cell carcinoma.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659355	PMC
http://dx.doi.org/10.1001/jamadermatol.2019.1541	DOI Listing

Publication Analysis

basal cell

topical itraconazole

itraconazole treatment

treatment basal

cell carcinoma

phase open-label

open-label placebo-controlled

basal

cell

carcinoma patients

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!